Gary M. Winer

Gary M. Winer has over 30 years of experience in the healthcare and biopharmaceutical industries. Gary is currently the Director at HCW Biologics. Prior to their current role, they served as the President and CEO of ORGENTEC Diagnostika GmbH, a company that provides consultation services to clients in the biopharma, medical device, and diagnostic health sectors with a focus on business strategy, product/portfolio planning, and commercialization in international markets. Gary is also a Japan market specialist.

Gary has also held positions as Vice President, Commercial Strategic Projects at AbbVie, President of Abbott Japan at Abbott Laboratories, and Principal at DRC Health Care Advisors. Gary has also served as a Board member and strategic advisor to the Chairman of Chroma Corporation, a privately held manufacturer of specialty industrial color compounds. Chroma Corporation was acquired by another company in July 2018.

Gary M. Winer has a Master of Business Administration (M.B.A.) from Northwestern University - Kellogg School of Management and a Bachelor of Science (B.S.) in Finance from California State University, Northridge.